Skip to main content

Table 3 Prevalence, 95% confidence intervals, and mean fluorescence intensities of IgG responses to PvETRAMPs in P. vivax malaria patients and healthy individuals

From: Evaluation of antibody responses to the early transcribed membrane protein family in Plasmodium vivax

Antigen (P. vivax)

Sample (n)

No. of samples

Sensitivity (%)/Specificity (%)

95% CI (%)

MFI

Cut-off valuea

t-value

P-valueb

Positive

Negative

ETRAMP4

Patients (50)

31

19

62.0/97.5

48.2–74.1

10,713 ± 10,787

52,033

4.341

< 0.0001

Healthy (40)

1

39

 

87.1–99.6

3276 ± 963.4

   

ETRAMP5

Patients (50)

24

26

48.0/95.0

34.8–61.5

6115 ± 5629

4579

3.877

0.0002

Healthy (40)

2

38

 

83.5–98.6

2620 ± 979.4

   

ETRAMP8

Patients (50)

23

27

46.0/95.0

32.8–59.6

6678 ± 6376

4589

3.600

0.0005

Healthy (40)

2

38

 

83.5–98.6

3023 ± 783.1

   

ETRAMP9

Patients (32)

14

18

43.8/100

28.2–60.7

4428 ± 2008

3968

2.015

0.05

Healthy (8)

0

8

 

67.6–100

2974 ± 497.2

   

ETRAMP10.3

Patients (50)

20

30

40.0/97.5

27.6–53.8

5880 ± 5540

4259

3.643

0.0005

Healthy (40)

1

39

 

87.1–99.6

2659 ± 799.8

   

ETRAMP11.2

Patients (56)

43

13

76.8/97.5

64.2–85.9

12,647 ± 3326

9733

10.39

< 0.0001

Healthy (40)

1

39

 

87.1–99.5

6811 ± 1461

   
  1. aCut-off, the mean fluorescence intensity of the malaria-naïve samples plus 2 standard deviations
  2. bP-value, the difference in the total IgG level for each antigen between P. vivax malaria patients and healthy individuals was calculated with the unpaired t-test. A P-value of < 0.05 was considered statistically significant
  3. Abbreviations: CI, confidence interval; MFI, mean fluorescence intensity